Psilocybin may provide long-lasting relief from chronic nerve pain
A single dose of psilocybin – the active compound in magic mushrooms – reduces nerve pain for up…
EFSA gives positive safety opinion on NMN
EFSA considers a daily intake of 300 mg of NMN to be safe for the general population, excluding…
Exploiting a new weakness in ‘zombie-like’ cells to treat senescence-associated diseases
A new set of drugs exploit a recently-revealed weakness in ‘zombie-like’ – or senescent – cells that could lead to new treatments for cancer and age-associated diseases. The study from the…
N.J. doctor who prescribed thousands of oxycodone pills sentenced to prison, feds say
A Paterson doctor who previously admitted distributing opioids without a legitimate medical reason was sentenced to seven years…
iHerb acquires Vitacost to accelerate U.S. market presence
“This is an exciting and highly complementary acquisition for iHerb,” said Emun Zabihi, chief executive officer of iHerb,…
India bans high-dose nimesulide: Health risks behind the decision
The government has banned nimesulide in doses above 100 mg, citing health risks linked to its use in…
Opioid receptor agonists take advantage of new understanding of GPCR biology
Opioid receptors are fantastic targets for treating pain—but unfortunately, the drugs that target them can be addictive.…
Florida man admits to getting kickbacks from N.J. pharmacy in telemarketing prescription scam
A Florida resident has admitted in federal court that he received more than $300,000 in kickbacks from a…
Prescription painkillers shortage in Canada expected to continue into new year
TORONTO — Pharmacists say a shortage of medications that contain oxycodone is expected to continue into the new…